JOHNSON & JOHNSON — Director's Dealing 2018

Sep 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2018-08-27

Reporting Person: McEvoy Ashley (EVP, WW Chair, Medical Devices)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-27	Common Stock	I	142.0000	$134.9200	Disposed	2215.0000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9476.0000	Direct
Common Stock	300.0000	Indirect

Footnotes

F1: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan.

F2: Shares held by ESOP under the Johnson & Johnson Savings Plan.